Intercept to Present at the Virtual Baird 2021 Global Healthcare Conference
September 01 2021 - 8:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat progressive
non-viral liver diseases, today announced that Jerry Durso,
President and Chief Executive Officer of Intercept, M. Michelle
Berrey, M.D., M.P.H., President of Research & Development and
Chief Medical Officer of Intercept, and Andrew Saik, Chief
Financial Officer of Intercept, will present at the virtual Baird
2021 Global Healthcare Conference on Tuesday, September 14,
2021 at 10:15 a.m. ET.
A live webcast of the event will be available on the investor
page of Intercept’s website at http://ir.interceptpharma.com.
An audio archive of the webcast will also be available on
Intercept’s website for approximately two weeks.
About Intercept
Intercept is a biopharmaceutical company focused on the
development and commercialization of novel therapeutics to treat
progressive non-viral liver diseases, including primary biliary
cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded
in 2002 in New York, Intercept has operations in the
United States, Europe and Canada. For more
information, please visit www.interceptpharma.com or
connect with the company
on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Apr 2023 to Apr 2024